Expanded Access to Bezuclastinib to be Coadministered With Sunitinib for Patients With Gastrointestinal Stromal Tumors
Cogent Biosciences, Inc.
Cogent Biosciences, Inc.
Bayer
AstraZeneca
Washington University School of Medicine
Indiana University
GlaxoSmithKline
M.D. Anderson Cancer Center
Indiana University